Skip to main content
. 2006 Sep;2(3):221–237. doi: 10.2147/vhrm.2006.2.3.221

Table 2.

Prognostic value of CRP in acute coronary syndromes

Study n Endpoint Cutoff Risk estimates
Short term
Liuzzo et al 1994 31 Death/MI/urg. revasc 3.0 mg/L RR=2.6
Morrow et al 1998 437 Death 15.5 mg/L RR=16.1
Rebuzzi et al 1998 102 MI 3 mg/L RR=6.0
Verheggen et al 1999 211 Refractory angina 6 mg/L OR=2.19
Oltrona et al 1997 140 Death/MI/revasc 10 mg/L p=ns
Montalescot et al 1998 68 Death/MI/angina/revasc 5 mg/L p=ns
Mid term
Ridker et al 2005 3,745 Death/MI 2 mg/L RR=1.4
Muller et al 2002 1,042 Death 10 mg/L OR=4.1
Heeschen et al 2000 447 Death/MI 10 mg/L RR=2.0
Lindhal et al 2000 917 Death 10 mg/L RR=2.6
Ferreiros et al 1999 194 Death/MI/refractory angina 15 mg/L HR=3.16
Biasucci et al 1999 53 UA 3 mg/L OR=8.6
Toss et al 1997 965 Death/MI >10 mg/L vs <2.0 mg/L RR=3.5
Haverkate et al 1997 2,121 Sudden death/MI 3.6 mg/L RR=2.0

Abbreviations: CRP, C-reactive protein; HR, hazard ratio; MI, myocardial infarction; Mid-term, in-hospital, 3–37 months; OR, odds ratio; RR, relative risk; Short term, in-hospital, 3 months; UA, unstable angina; urg. revasc, urgent revascularization.

HHS Vulnerability Disclosure